+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Paclitaxel"

Breast Cancer Treatment Drug Markets in China - Product Thumbnail Image

Breast Cancer Treatment Drug Markets in China

  • Report
  • July 2023
  • 256 Pages
  • China
From
Ovarian Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Ovarian Cancer Treatment Drugs Companies in China

  • Report
  • July 2023
  • 88 Pages
  • China
From
Ovarian Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Ovarian Cancer Treatment Drugs Markets in China

  • Report
  • July 2023
  • 272 Pages
  • China
From
From
From
From
Loading Indicator

Paclitaxel is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel works by interfering with the normal process of cell division, preventing cancer cells from dividing and growing. It is typically used in combination with other drugs, such as doxorubicin, to treat advanced stages of breast cancer. Paclitaxel is available in both intravenous and oral formulations, and is often used in combination with other drugs to treat metastatic breast cancer. It is also used to treat other types of cancer, such as ovarian and lung cancer. Paclitaxel is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and Sanofi. It is also available as a generic drug in some countries. Companies in the Paclitaxel market include Bristol-Myers Squibb, Pfizer, Sanofi, Mylan, Teva Pharmaceuticals, and Apotex. Show Less Read more